Avadel Pharmaceuticals plc (AVDL)

4.77 0 (0%)

IEX Real-Time Price

August 16, 2018 EST.

NASDAQ Global Market : Healthcare

Prev Close 4.77

Price Open 4.94

Volume: 430,148

Avg Volume: 268,334

Market Cap: 175.37M

P/E Ratio -4.42

52 Wk Range 4.664-11.93



AVDL Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-07-31
35.8M
2.24M
10.29
6.25%

2018-07-13
35.78M
2.35M
5.31
6.57%

2018-06-29
35.78M
2.28M
5.23
6.38%

2018-06-15
35.78M
3.31M
8.74
9.25%




AVDL Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-05-08
Q1 2018
N/A
-0.30 (1)
0.00
0.00

2018-05-02
Q1 2018
N/A
-0.30 (1)
-0.34
-0.04

2018-03-08
Q4 2017
BTO
-0.23 (2)
-0.28
-0.05

2018-03-06
Q4 2017
N/A
-0.23 (2)
-0.28
-0.05

News

Avadel Pharmaceuticals plc 2018 Q2 - Results - Earnings Call Slides (2018-08-08 13:52 SeekingAlpha)

The following slide deck was published by Avadel Pharmaceuticals plc in conjunction with their 2018 Q2 earnings Read more …

 


Statistics

Shares Outstanding: 36.76M

Top 15 Institution Percent: 68.00

Price To Sales: 1.32

Price To Book: 2.29

Revenue: 39.68M

Gross Profit: 35.89M

Cash: 115.61M

Debt: 915000

Return On Assets: -0.81

Return On Equity: -2.89

Profit Margin: -1.64

Price History

Beta: 4.19

50-day Moving Avg: 6.46

200-day Moving Avg: 7.84

YTD Change: -45.80

5-day Change: -3.44

1-month Change: -30.57

3-month Change: -30.87

6-month Change: -38.37

1-year Change: -45.86

Revenue Per Share: 1.00

Revenue Per Employee: 220417.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Avadel Pharmaceuticals plc

Exchange: NASDAQ Global Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.avadel.com

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company developing and commercializing pharmaceutical products. The company's products include Bloxiverz, Vazculep, Akovaz, Karbinal ER, AcipHex Sprinkle, Cefaclor and Flexichamber.